1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]- manufacturers
|
| | 1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]- Basic information |
| Product Name: | 1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]- | | Synonyms: | 1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]-;WAY-643116;6-((Methyl(phenyl)amino)methyl)-N2-(o-tolyl)-1,3,5-triazine-2,4-diamine;Therapeutic agent-1 | | CAS: | 850020-01-8 | | MF: | C18H20N6 | | MW: | 320.39 | | EINECS: | | | Product Categories: | | | Mol File: | 850020-01-8.mol | ![1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]- Structure](CAS/20210305/GIF/850020-01-8.gif) |
| | 1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]- Chemical Properties |
| Boiling point | 559.7±60.0 °C(Predicted) | | density | 1.269±0.06 g/cm3(Predicted) | | form | Solid | | pka | 3.87±0.10(Predicted) | | color | White to off-white |
| | 1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]- Usage And Synthesis |
| Uses | Therapeutic agent-1 is a heteroaryl compound that can be used in Gaucher disease glucocerebrosidase activity enzyme replacement therapy[1]. | | References | [1] Heteroaryl compounds and their use. WO2018122775 |
| | 1,3,5-Triazine-2,4-diamine, N2-(2-methylphenyl)-6-[(methylphenylamino)methyl]- Preparation Products And Raw materials |
|